HopeStageGet research updates
HopeStage
hi@hopestage.com

Built by people with lived experience, between Sydney and Paris.

Back to all studies
CompletedEUCTR 2012-004579-37

Animal and human serotonergic model of schizophrenia: validity evaluated by qEEG and fMRI

This historical record does not confirm current site availability.

Historical research recordCzechia
The study in practice

Understand this study

What did researchers investigate?

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.

Listed locations
Czechia
Study phase
Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateNot clearly listed
Recruitment status
Completed
Enrollment listed in the registry
Not clearly listed
Sponsor
National Institute of Mental Health
Sponsor type
Research institute
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 1, Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
Locations
Czechia
Age range
Not clearly listed
Official registry ID
EUCTR 2012-004579-37
Official title
Show the full official title

Animal and human serotonergic model of schizophrenia: validity evaluated by qEEG and fMRI

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Czechia

Registry details
Historical country statuses
FAQ

Questions about this study

Who is behind this study?

The study sponsor is National Institute of Mental Health, a research institute.

Want to explore more studies?

Explore studies